KLK3 and benign prostatic hyperplasia: PSA cannot reliably differentiate between benign prostate conditions [prostatitis and benign prostatic hyperplasia (BPH)], indolent cancers (unlikely to cause symptoms or death in a man's lifetime) and aggressive/ advanced cancers that will likely cause symptoms and/or death if not treated promptly.